Skip to main content
. 2015 Aug 20;6(6):785–791. doi: 10.1111/1759-7714.12303

Table 4.

Distribution of UGT1A1 of patients treated with IP (n = 30)

Genotype Genotype n (%)
UGT1A1*28 (n) UGT1A1*6 (n)
TA6/6 (20) G/G (21) Wild-type 12 (40.0)
TA6/6 (20) A/G (8) Single mutation 7 (23.4)
TA6/7 (7) G/G (21) Singe mutation 6 (20.0)
TA6/7 (7) A/G (8) Double mutation 1 (3.3)
TA7/7 (3) G/G (21) Double mutation 3 (10.0)
TA6/6 (20) A/A (1) Double mutation 1 (3.3)

IP, irinotecan plus cisplatin; UGT1A1, uridine diphosphate glucuronosyltransferase.